Riskpilot← Back to searchSign inGet full accessCarmen Consulting AB
ABActiveOrg 5592504715Digertäktsvägen 26Medical specialists activities · NACE 8622Est. 20200 employees
Revenue 2024
SEK 22K
-84% vs 2023
EBITDA margin
-107.1%
-155% vs 2023
Equity ratio
58.0%
Financial strength
Net profit 2024
SEK -24K
-201% vs 2023
| Revenue | SEK 22K | -84% |
| EBITDA | SEK -23K | -155% |
| Net profit | SEK -24K | -201% |
| Total assets | SEK 34K | -50% |
| Equity | SEK 19K | -55% |
| Employees | 0 | — |
Legal name
Carmen Consulting AB
Org number
5592504715
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
31 mars 2020
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva verksamhet inom medicinsk vård, särskilt reumatologi. Den medicinska vården bedrivs till exempel genom konsultläkartjänster. Därutöver erbjuder bolaget även konsulttjänster inom reumatologi och vårdutveckling, samt utbildningar och föreläsningar inom hälso- och sjukvård.
Address
Digertäktsvägen 26
Email
vrosig@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 21 | 39 | 58 | 138 | 22 |
| Staff expenses | — | — | −21 | −0 | — |
| EBITDA | 4 | 24 | −5 | 43 | −23 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | 4 | 24 | −5 | 43 | −23 |
| Net financials | — | — | −1 | −0 | −0 |
| Profit before tax | 4 | 24 | −5 | 31 | −24 |
| Tax | −1 | −5 | — | −7 | — |
| Net profit | 3 | 19 | −5 | 23 | −24 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 30 | 58 | 22 | 68 | 34 |
| Equity | 28 | 47 | 20 | 43 | 19 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 1 | 11 | 3 | 13 | 2 |
| Total debt | 1 | 11 | 3 | 13 | 2 |
EBITDA margin
-107.1%
This company
15.8%
Market median
-778% vs market
20202024
Equity ratio
58.0%
This company
38.2%
Market median
+52% vs market
20202024
Return on equity
-122.0%
This company
18.4%
Market median
-763% vs market
20202024
Net profit margin
-108.4%
This company
8.1%
Market median
-1438% vs market
20202024
Asset turnover
0.65×
This company
1.12×
Market median
-42% vs market
20202024
Debt / equity
0.72×
This company
0.62×
Market median
+16% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-04-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Carmen Consulting AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Valgerdur Ros Sigurdardottir | Board of Directors | 0 companies |
| Thorhildur Margrét Danielsdottir | Deputy Board Member | 0 companies |